# Luminous Ventures

> Luminous Ventures is a VC fund in London backing Health Care and Software. See 22 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 22
- Last investment: Jun 2021
- Lead investor: 41%
- Fund size: $29M
- Last fund: Dec 2018
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/luminousventures
- Website: https://luminous.vc

Luminous Ventures is a London-based VC fund investing in Deep Tech with a focus on the application of innovative technologies to healthcare, life science, nutrition, food and agriculture. Investing at Seed and Series A, Luminous has backed companies in Europe and North America.

## Contacts

5 contacts available for Luminous Ventures. Shizune tracks 3 team members at Luminous Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/luminous-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $616k–$4.6M |
| Series A | $9.3M–$26M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 32% |
| Software | 6 | 27% |
| Artificial Intelligence | 5 | 23% |
| Machine Learning | 4 | 18% |
| Information Technology | 4 | 18% |

32 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 9 | 41% |
| Funding Round | 5 | 23% |
| Series A | 3 | 14% |
| Pre-Seed | 1 | 5% |
| Series B | 1 | 5% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 12 | 55% |
| Canada | 1 | 5% |
| Singapore | 1 | 5% |
| United States | 1 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alasdair Thong | Venture Partner | 8 | https://shizune.co/investors/profile/alasdair-thong |
| Lomax Ward | Founding Partner | 5 | https://shizune.co/investors/profile/lomax-ward |
| Miao He | Associate | 0 | https://shizune.co/investors/profile/miao-he |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ellipsis Health | Sage provides 24/7 support and simplified healthcare navigation, guiding patients through complex healthcare processes with empathetic conversation. | $26M | Series A | Jun 15, 2021 |  |
| Treos Bio | Treos Bio, Inc. is a computational immunology and immunotherapy company which has developed a proprietary technology to predict in silico likely responders to cancer immunotherapies and to design in silico next generation targeted immunotherapies for a large population of cancer patients. | $16.4M | Convertible Note | Mar 31, 2021 |  |
| LGN | LGN is a developer of artificial perception technology used to balance and automatically connect the AI system to the sensor array. Its technology reduces capture and processing costs by automatically filtering data to only record and process edge cases and by transferring and storing data in a highly compressed form that enable industries with areduced chip cost and power consumption whilst allowing high-level autonomy on lower-cost commodity sensors. | $1.9M | Seed | Mar 23, 2021 |  |
| Universal Quantum | Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve. | $4.5M | Seed | Jun 14, 2020 |  |
| Oxford VR | Oxford VR is a spin out from Oxford University built on the work of Professor Daniel Freeman who has been developing effective VR-based mental health treatments for 15 years. Ground-breaking research, combined with the advent of highly immersive consumer VR, means that we can provide to millions treatments that are: faster and more effective thantraditional treatments; significantly lower cost to health providers; loved by users. Our focus is on developing clinically validated, cost-effective, user-centred treatments for clinical conditions with significant impact on patients, the health system and wider economy. | $13M | Series A | Feb 12, 2020 |  |
| LGN | LGN is a developer of artificial perception technology used to balance and automatically connect the AI system to the sensor array. Its technology reduces capture and processing costs by automatically filtering data to only record and process edge cases and by transferring and storing data in a highly compressed form that enable industries with areduced chip cost and power consumption whilst allowing high-level autonomy on lower-cost commodity sensors. | $615.6K |  | Oct 31, 2019 |  |
| LGN | LGN is a developer of artificial perception technology used to balance and automatically connect the AI system to the sensor array. Its technology reduces capture and processing costs by automatically filtering data to only record and process edge cases and by transferring and storing data in a highly compressed form that enable industries with areduced chip cost and power consumption whilst allowing high-level autonomy on lower-cost commodity sensors. | $615.6K | Seed | Oct 31, 2019 |  |
| Optellum | Optellum develops an imaging biomarker for smart lung cancer detection. Optellum’s vision is to redefine cancer care, by enabling every clinician, in every hospital, to manage their patients in the optimal way. They do that by providing end-end IT platform for personalized early diagnosis and therapy, based on the collective experience ofthousands of doctors pooled by machine learning applied to vast patient datasets. Their first suite of products targets management of patients at high risk of developing lung cancer – the world’s deadliest and commonest cancer – from early diagnosis through to treatment. Optellum comprises a team of award-winning medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision lab. Between us, they have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO. They are backed by an Advisory Board comprising world-leading clinicians and experts in deep learning ; and Oxford's most prominent investors. They are building up their product development team – join their fight against cancer, working together with former software engineers from top technology companies (Amazon, Facebook, Redhat) and veterans of medical imaging startups (e.g. Mirada Solutions – acquired by Siemens). | $1.3M | Seed | Jul 16, 2019 |  |
| Astroscreen | Astroscreen protects brands and defends democracy from harmful social media manipulation campaigns also known as astroturfing. | $1M | Seed | Apr 18, 2019 |  |
| Hadean | Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE. | $9.3M |  | Mar 07, 2019 |  |

10 of 22 investments shown.

## Co-investors
- [AI Seed](https://shizune.co/investors/profile/ai-seed-fund) — VC Fund, 4 deals together
- [InMotion Ventures](https://shizune.co/investors/profile/inmotion-ventures) — VC Fund, 3 deals together
- [Inovia Capital](https://shizune.co/investors/profile/inovia-capital) — VC Fund, 3 deals together
- [IQ Capital](https://shizune.co/investors/profile/iq-capital-partners) — VC Fund, 3 deals together
- [7percent Ventures](https://shizune.co/investors/profile/7-percent) — VC Fund, 2 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-science-enterprises) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund
- [Great Oaks Venture Capital](https://shizune.co/investors/profile/great-oaks-venture-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Artificial intelligence VC Funds in United Kingdom](https://shizune.co/investors/artificial-intelligence-vc-funds-united-kingdom)
- [Artificial intelligence Investors in United Kingdom](https://shizune.co/investors/artificial-intelligence-investors-united-kingdom)
- [Sports VC Funds in United Kingdom](https://shizune.co/investors/sports-vc-funds-united-kingdom)
- [Fitness VC Funds in United Kingdom](https://shizune.co/investors/fitness-vc-funds-united-kingdom)
- [Platforms VC Funds in United Kingdom](https://shizune.co/investors/platforms-vc-funds-united-kingdom)
- [Life Science Investors in United Kingdom](https://shizune.co/investors/life-science-investors-united-kingdom)

## FAQ

### What does Luminous Ventures invest in?

Luminous Ventures invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Seed and Funding Round stage. Most of the 22 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Luminous Ventures's check size?

Luminous Ventures typically joins rounds of $616k–$4.6M at Seed and $9.3M–$26M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Luminous Ventures participates in.

### How do I contact Luminous Ventures?

Public channels for Luminous Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Luminous Ventures?

The team at Luminous Ventures includes Alasdair Thong (Venture Partner), Lomax Ward (Founding Partner) and Miao He (Associate). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co